• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV 储存库:治愈 HIV 感染的抗病毒免疫反应和免疫干预措施。

HIV reservoir: antiviral immune responses and immune interventions for curing HIV infection.

机构信息

Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.

Laboratoire d'ImmunoRhumatologie Moléculaire, Institut national de la santé et de la recherche médicale (INSERM) UMR_S 1109, Institut thématique interdisciplinaire (ITI) de Médecine de Précision de Strasbourg, Transplantex NG, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg 67000, France.

出版信息

Chin Med J (Engl). 2022 Nov 20;135(22):2667-2676. doi: 10.1097/CM9.0000000000002479.

DOI:10.1097/CM9.0000000000002479
PMID:36719355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9943973/
Abstract

Antiretroviral therapy against human immunodeficiency virus (HIV) is effective in controlling viral replication but cannot completely eliminate HIV due to the persistence of the HIV reservoir. Innate and adaptive immune responses have been proposed to contribute to preventing HIV acquisition, controlling HIV replication and eliminating HIV-infected cells. However, the immune responses naturally induced in HIV-infected individuals rarely eradicate HIV infection, which may be caused by immune escape, an inadequate magnitude and breadth of immune responses, and immune exhaustion. Optimizing these immune responses may solve the problems of epitope escape and insufficient sustained memory responses. Moreover, immune interventions aimed at improving host immune response can reduce HIV reservoirs, which have become one focus in the development of innovative strategies to eliminate HIV reservoirs. In this review, we focus on the immune response against HIV and how antiviral immune responses affect HIV reservoirs. We also discuss the development of innovative strategies aiming to eliminate HIV reservoirs and promoting functional cure of HIV infection.

摘要

抗人类免疫缺陷病毒 (HIV) 的抗病毒治疗在控制病毒复制方面非常有效,但由于 HIV 储存库的持续存在,无法完全消除 HIV。先天和适应性免疫反应被认为有助于预防 HIV 感染、控制 HIV 复制和消除 HIV 感染细胞。然而,HIV 感染者自然诱导的免疫反应很少能根除 HIV 感染,这可能是由于免疫逃逸、免疫反应的幅度和广度不足以及免疫衰竭所致。优化这些免疫反应可能解决表位逃逸和持续记忆反应不足的问题。此外,旨在改善宿主免疫反应的免疫干预可以减少 HIV 储存库,这已成为开发消除 HIV 储存库的创新策略的一个重点。在这篇综述中,我们重点讨论了针对 HIV 的免疫反应以及抗病毒免疫反应如何影响 HIV 储存库。我们还讨论了旨在消除 HIV 储存库和促进 HIV 感染功能性治愈的创新策略的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b37/9943973/5c2c647d04e6/cm9-135-2667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b37/9943973/394b68f2f09a/cm9-135-2667-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b37/9943973/5c2c647d04e6/cm9-135-2667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b37/9943973/394b68f2f09a/cm9-135-2667-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b37/9943973/5c2c647d04e6/cm9-135-2667-g002.jpg

相似文献

1
HIV reservoir: antiviral immune responses and immune interventions for curing HIV infection.HIV 储存库:治愈 HIV 感染的抗病毒免疫反应和免疫干预措施。
Chin Med J (Engl). 2022 Nov 20;135(22):2667-2676. doi: 10.1097/CM9.0000000000002479.
2
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.HIV-1储存库:在抗病毒免疫反应和抗逆转录病毒疗法存在的情况下病毒持续存在的机制
Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665.
3
HIV Persistence in Adipose Tissue Reservoirs.脂肪组织储存库中的 HIV 持续存在。
Curr HIV/AIDS Rep. 2018 Feb;15(1):60-71. doi: 10.1007/s11904-018-0378-z.
4
Colony-Stimulating Factor 1 Receptor Antagonists Sensitize Human Immunodeficiency Virus Type 1-Infected Macrophages to TRAIL-Mediated Killing.集落刺激因子1受体拮抗剂使1型人类免疫缺陷病毒感染的巨噬细胞对TRAIL介导的杀伤敏感。
J Virol. 2016 Jun 24;90(14):6255-6262. doi: 10.1128/JVI.00231-16. Print 2016 Jul 15.
5
HIV-Specific Granzyme B-Secreting but Not Gamma Interferon-Secreting T Cells Are Associated with Reduced Viral Reservoirs in Early HIV Infection.在早期HIV感染中,分泌HIV特异性颗粒酶B而非分泌γ干扰素的T细胞与病毒储存库减少有关。
J Virol. 2017 Mar 29;91(8). doi: 10.1128/JVI.02233-16. Print 2017 Apr 15.
6
Selective BCL-X Antagonists Eliminate Infected Cells from a Primary-Cell Model of HIV Latency but Not from Reservoirs.选择性 BCL-X 拮抗剂可从 HIV 潜伏期的原代细胞模型中清除受感染细胞,但不能从储库中清除。
J Virol. 2021 Jul 12;95(15):e0242520. doi: 10.1128/JVI.02425-20.
7
Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.在原发性HIV-1感染时开始的长期抗逆转录病毒治疗会影响HIV-1感染的CD4 T细胞储存库的大小、组成和衰减动力学。
J Virol. 2014 Sep 1;88(17):10056-65. doi: 10.1128/JVI.01046-14. Epub 2014 Jun 25.
8
Single-Cell Profiling of Latently SIV-Infected CD4 T Cells Directly to Reveal Host Factors Supporting Reservoir Persistence.单细胞分析潜伏感染 SIV 的 CD4 T 细胞以直接揭示支持储库持久性的宿主因素。
Microbiol Spectr. 2022 Jun 29;10(3):e0060422. doi: 10.1128/spectrum.00604-22. Epub 2022 May 5.
9
Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir.靶向持续性人类免疫缺陷病毒储存库的细胞介导免疫。
J Infect Dis. 2017 Mar 15;215(suppl_3):S160-S171. doi: 10.1093/infdis/jix002.
10
Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.在抗逆转录病毒治疗期间,对持续性HIV-1进行有效的细胞毒性T淋巴细胞靶向需要初始CD8 + T细胞的启动。
mBio. 2016 May 31;7(3):e00473-16. doi: 10.1128/mBio.00473-16.

引用本文的文献

1
Immune Control of AIDS Progression by an Adenovirus-Based Therapeutic Vaccination in Acute Simian Immunodeficiency Virus-Infected Macaques.基于腺病毒的治疗性疫苗对急性感染猿猴免疫缺陷病毒的猕猴艾滋病进展的免疫控制
MedComm (2020). 2025 Aug 1;6(8):e70309. doi: 10.1002/mco2.70309. eCollection 2025 Aug.
2
HIV controllers: hope for a functional cure.HIV 控制者:功能性治愈的希望。
Front Immunol. 2025 Feb 25;16:1540932. doi: 10.3389/fimmu.2025.1540932. eCollection 2025.
3
Inhibition of TIGIT on NK cells improves their cytotoxicity and HIV reservoir eradication potential.
抑制TIGIT对自然杀伤细胞(NK细胞)的作用可提高其细胞毒性及清除HIV储存库的潜力。
mBio. 2025 Mar 12;16(3):e0322624. doi: 10.1128/mbio.03226-24. Epub 2025 Feb 7.
4
Interactions between human immunodeficiency virus and human endogenous retroviruses.人类免疫缺陷病毒与人类内源性逆转录病毒之间的相互作用。
J Virol. 2025 Mar 18;99(3):e0231924. doi: 10.1128/jvi.02319-24. Epub 2025 Feb 7.
5
Special Issue "The Role of Toll-Like Receptors (TLRs) in Infection and Inflammation 2.0".特刊:“Toll 样受体(TLRs)在感染和炎症中的作用 2.0”
Int J Mol Sci. 2024 Sep 7;25(17):9709. doi: 10.3390/ijms25179709.
6
Demographic and clinical factors correlated with clinical outcomes among people with HIV treated by antiretroviral therapy: a retrospective cohort study.人口统计学和临床因素与接受抗逆转录病毒治疗的 HIV 感染者的临床结局相关:一项回顾性队列研究。
BMC Infect Dis. 2024 May 22;24(1):514. doi: 10.1186/s12879-024-09406-w.
7
Development of a droplet digital polymerase chain reaction assay for the sensitive detection of total and integrated HIV-1 DNA.开发一种用于敏感检测总 HIV-1 DNA 和整合 HIV-1 DNA 的液滴数字聚合酶链反应检测法。
Chin Med J (Engl). 2024 Mar 20;137(6):729-736. doi: 10.1097/CM9.0000000000003081. Epub 2024 Mar 4.
8
Targeting the HIV reservoir: chimeric antigen receptor therapy for HIV cure.靶向 HIV 储存库:嵌合抗原受体治疗 HIV 治愈。
Chin Med J (Engl). 2023 Nov 20;136(22):2658-2667. doi: 10.1097/CM9.0000000000002904. Epub 2023 Nov 6.
9
HIV Infection: Shaping the Complex, Dynamic, and Interconnected Network of the Cytoskeleton.HIV 感染:塑造细胞骨架的复杂、动态和相互关联的网络。
Int J Mol Sci. 2023 Aug 23;24(17):13104. doi: 10.3390/ijms241713104.